Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making waves in the industry with its innovative product pipeline and strong market performance.

Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that ...

In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...

The device uses acoustic pressure waves created in a balloon catheter to fracture calcium buildup on the insides of blood vessels. Boston Scientific, the third-largest medical device-maker in the ...

Since Boston Scientific launched its Farapulse PFA system and Medtronic introduced PulseSelect, the FDA has approved ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

FSM Wealth Advisors LLC lifted its position in Boston Scientific Co. (NYSE:BSX – Free Report) by 3.0% during the 4th quarter, ...

Boston Scientific (NYSE:BSX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Wednesday. Several other research analysts also ...

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Boston Scientific (BSX) to $115 from $95 and keeps an Overweight rating on ...

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and ...

Continuing its acquisition streak into 2025, Marlborough-based medical device manufacturer Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...